Language
English
Publication Date
11-1-2023
Journal
EJHaem
DOI
10.1002/jha2.787
PMID
38024612
PMCID
PMC10660108
PubMedCentral® Posted Date
9-7-2023
PubMedCentral® Full Text Version
Post-print
Abstract
Lymphoma is one of the most common cancers in adolescents and young adults, but historically, this population has had lower clinical trial enrollment and improvements in overall survival as compared to other age populations. There are multiple challenges that are unique to this population that have affected drug development and clinical trial enrollment. Our panel of experts have identified barriers, and in this review, we discuss current methods to address these barriers as well as potential solutions moving forward.
Keywords
adolescent and young adults, clinical trials, lymphomas, new drug development
Published Open-Access
yes
Recommended Citation
Toner, Keri; Allen, Carl E; Jain, Shweta; et al., "Overcoming Barriers to Drug Development and Enrollment in Clinical Trials for Adolescents and Young Adults With Lymphoma" (2023). Faculty, Staff and Students Publications. 6418.
https://digitalcommons.library.tmc.edu/baylor_docs/6418